50% off the $29.99 Custom Kit. Use at checkout:
⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
AEO Score: 4/10
Monitoring for AI engine activity
In the Engagemii AEO index
#305,217 of 469,579 in Healthcare for AI visibility
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Ozempic® (semaglutide) GLP just got measured.
4/10 means Ozempic® (semaglutide) GLP is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.
Ozempic® (semaglutide) is a GLP-1 RA type 2 diabetes treatment that is available in an injectable pen or pill. Read Important Safety Information, including Boxed Warning.
Industry: Healthcare
bgtmds.com2
Structured Data
6
Content Structure
7
Entity Clarity
2
E-E-A-T Signals
6
Technical AEO
4
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Ozempic® (semaglutide) GLP.
Scored by Engagemii on July 15, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/bgtmds
Cite this score: Engagemii (2026). "AEO Score for Ozempic® (semaglutide) GLP." Retrieved from https://engagemii.com/aeo/brands/bgtmds
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - The Answer Engine Optimization (AEO) Platform